92768 ⎘
Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by amino groups with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by a carbon atom of a six-membered aromatic ring having the carbon atom of the carboxamide group bound to a hydrogen atom or to a carbon atom of a saturated carbon skeleton
ANTICANCER COMPOUNDS
#2Fluorophenyl beta-hydroxyethylamines and their use in the treatment of hyperglycaemia
#3ARYL AND PYRIDYL AMIDE PESTICIDES AND COMPOSITIONS THEREOF
#4Substituted piperazines as disrupters of AB42 oligomer formation
#5SMALL-CELL POLYSTYRENE FOAMS, AND PROCESS FOR PRODUCING SAME
#6Anticancer compounds
#7Vesicular Monoamine Transporter-2 Ligands and Their Use in the Treatment of Psychostimulant Abuse
#8BIS(2-HALOACETAMIDO)-COMPOUNDS FOR USE AS LINKING AGENTS AND RESULTANT PRODUCTS WHICH COMPRISE ANTIBODIES, HALF-ANTIBODIES AND ANTIBODY FRAGMENTS
#9COMPOUNDS AND METHODS TO ATTENUATE TUMOR PROGRESSION AND METASTASIS
#10Fluorinated 2-amino-4-(substituted amino)phenyl carbamate derivatives
#11Amphoteric liposomes comprising imino lipids
#12Vesicular monoamine transporter-2 ligands and their use in the treatment of psychostimulant abuse
#13Fluorophenyl beta-hydroxyethylamines and their use in the treatment of hyperglycaemia
#14Pharmacophores, compounds and methods having application in the treatment of cancer through inhibition of CYP17A1 and CYP19A1
#15Substituted amines as disrupters of ABETA42 oligomer formation
#16COMPOSITIONS AND METHODS OF MAKING EXPANDED HEMATOPOIETIC STEM CELLS USING PTEN INHIBITORS
#17COMPOSITIONS AND METHODS OF REGULATING CANCER RELATED DISORDERS AND DISEASES
#18Resin composition
#19Small molecule drugs and related methods for treatment of diseases related to Aβ42 oligomer formation
#20Fluorinated 4-(substituted amino)phenyl carbamate derivatives
#21Two-dimensional nanomaterial dispersant, preparation method of two-dimensional nanomaterial by liquid phase exfoliation, and use thereof
#22Fluorinated cyclopropylamine compound, preparation method therefor, pharmaceutical composition thereof, and uses thereof
#23Composition for preventing or treating hair loss including benzene diamine derivative
#24AMPHOTERIC LIPOSOMES COMPRISING IMINO LIPIDS
#25Inhibitors of histone deacetylase
#26Sodium channel modulators
#27Process for the preparation of clobazam and its intermediate
#28INHIBITORS OF HISTONE DEACETYLASE
#29FLUORINATED 2-AMINO-4-(SUBSTITUTED AMINO)PHENYL CARBAMATE DERIVATIVES
#302,2′-diaminobiaryls having a phthaloyl group or succinoyl group
#312,2' -DIAMINO BIARYLS WITH TWO SECONDARY AMINES AND PRODUCTION THEREOF BY ELECTROCHEMICAL COUPLING
#322,2′-diaminobiaryls having one primary and one secondary amine
#332,2′-diaminobiaryls having two secondary amines
#34Organic compounds, light modulating composition and light modulating devices employing the same
#35Buprenorphine dimer and its use in treatment of gastrointestinal disorders
#36Method of treating insomnia with halogenated pyrazolo[1,5-a]pyrimidines
#37Inhibitors of histone deacetylase
#38Imino compounds for amphoteric liposomes and uses thereof
#39METHOD FOR DYEING KERATINOUS SUBSTANCES STARTING FROM COLOURED OLIGOMERS AND/OR POLYMERS RESULTING FROM META-PHENYLENEDIAMINES, COMPOSITION AND DYEING AGENT
#401,3-Di-oxo-indene derivative, pharmaceutically acceptable salt or optical isomer thereof, preparation method thereof, and pharmaceutical composition containing same as an antiviral, active ingredient
#41Inhibitors of histone deacetylase
#42Inhibiting neurotransmitter reuptake
#43Pharmaceutically active dimers linked through phenolic hydroxyl groups
#44Buprenorphine dimer and its use in treatment of gastrointestinal disorders
#45Electric conduction through supramolecular assemblies of triarylamines
#46Acetamide stereoisomer
#47DERIVATIVES OF 4-(2-AMINO-1-HYDROXYETHYL)PHENOL AS AGONISTS OF THE BETA2 ADRENERGIC RECEPTOR
#48Inhibitors targeting drug-resistant influenza A
#49Small molecules modulator of epigenetic regulation and their therapeutic applications
#50Polymorphic form of a long-acting beta-2 adrenoceptor agonist
#51Treatment of friedreich's ataxia using histone deacetylase inhibitors
#52NOVEL MELATONIN LIGANDS HAVING ANTIDEPRESSANT ACTIVITY AS WELL AS SLEEP INDUCING PROPERTIES
#53BETA2-adrenoceptor agonists
#54Compound as KCNQ potassium channel agonist, preparation method therefor and use thereof
#55Compounds for treating ophthalmic diseases and disorders
#56Acetamide stereoisomer
#571,3-di-oxo-indene derivative, pharmaceutically acceptable salt or optical isomer thereof, preparation method thereof, and pharmaceutical composition containing same as an antiviral, active ingredient
#58Inhibitors of histone deacetylase
#59Inhibitors of histone deacetylase
#60Halogenated Pyrazolo[1,5-A]Pyrimidines, Processes, Uses, Compositions and Intermediates
#61Small molecules modulator of epigenetic regulation and their therapeutic applications
#62Halogenated diethyltoluenediamines
#631, 2-disubstituted amido-anthraquinone derivatives, preparation method and application thereof
#64Electric conduction through supramolecular assemblies of triarylamines
#65ANTHRAQUINONE -BASED COMPOUND, THE SYNTHESIS PROCESSES AND THE APPLICATION THEREOF
#66Beta-2-adrenoreceptor agonists
#67Process for the preparation of aromatic formamides
#68AMPHOTERIC LIPOSOMES COMPRISING IMINO LIPIDS
#69Process for the preparation of tapentadol and intermediates thereof
#70Amines or amino alcohols as GLYT1 inhibitors
#71Novel Compounds 621
#72Derivatives of 4-(2-Amino-1-Hydroxyethyl) Phenol as Agonists of the Beta2 AdrenergicReceptor
#73FORMOTEROL TARTRATE PROCESS AND POLYMORPH
#74Derivatives of 4-(2-amino-1-hydroxyethyl)phenol as agonists of the β2 adrenergic receptor
#75Beta-2-adrenoreceptor agonists
#76ARYL ANILINE DERIVATIVES AS BETA2 ADRENERGIC RECEPTOR AGONISTS
#77PURIFICATION PROCESS FOR PREPARING HIGHLY PURE ARFORMOTEROL TARTRATE SUBSTANTIALLY FREE OF DESFORMYL IMPURITY
#78PROCESSES FOR PREPARING SUBSTANTIALLY PURE ARFORMOTEROL AND ITS INTERMEDIATES
#79Process for the preparation of N-[5-(3-dimethylamino-acryloyl)-2-fluoro-phenyl]-N-methyl-acetamide
#80Small molecules modulator of epigenetic regulation and their therapeutic applications
#81Derivatives of 4-(2-amino-1-hydroxyethyl)phenol as agonists of the BETA2 adrenergic receptor
#82DERIVATIVES OF 4-(2-AMINO-1-HYDROXYETHYL)PHENOL AS AGONISTS OF THE BETA2 ADRENERGIC RECEPTOR
#83Substituted arylamino-1,2,3,4-tetrahydro naphthalenes and -2,3-dihydro--indenes as potassium channel modulators
#841, 2-disubstituted amido-anthraquinone derivatives, preparation method and application thereof
#85Group of amino substituted benzoyl derivatives and their preparation and their use
#86Process for the synthesis of arformoterol
#87Aminoalkylphenyl antagonists of prostaglandin D2 receptors
#88Method for producing aminobiphenylene
#89Beta-2-adrenoreceptor agonists
#90TREATMENT OF FRIEDREICH'S ATAXIA USING HISTONE DEACETYLASE INHIBITORS
#91Derivatives of 4-(2-amino-1-hydroxyethyl)phenol as agonists of the β2 adrenergic receptors
#92Compound capable of inhibiting 17-beta hydroxysteriod dehydrogenase
#93Melatonin ligands having antidepressant activity as well as sleep inducing properties
#94Process for the palladium-catalyzed coupling of terminal alkynes with aryl tosylates
#95Formoterol tartrate process and polymorph
#96AMINES OR AMINO ALCOHOLS AS GLYT1 INHIBITORS
#97Formoterol tartrate process and polymorph
#98DERIVATIVES OF 4-(2-AMINO-1-HYDROXYETHYL)PHENOL AS AGONISTS OF THE BETA2 ADRENERGIC RECEPTOR
#99Crystalline form of a βadrenergic receptor agonist
#100Compounds for treating ophthalmic diseases and disorders
#101Aryl aniline derivatives as βadrenergic receptor agonists
#102Chemical process and new crystalline form
#103SUBSTITUTED ANILINE DERIVATIVES
#104AMINE DERIVATIVES AND THEIR USE IN BETA-2-ADRENORECEPTOR MEDIATED DISEASES
#105Beta-2-adrenoreceptor agonists
#106DEUTERIUM-ENRICHED ARFORMOTEROL
#107Substituted hydroxyethylamine aspartyl protease inhibitors
#108Amine Derivatives
#109SYNTHESIS, TELOMERASE INHIBITION AND CYTOTOXIC STUDIES ON 2,7-DISUBSTITUTED ANTHRAQUINONE DERIVATIVES
#110SELECTIVE ACYLATION OF 4-SUBSTITUTED-1,3-PHENYLENEDIAMINE
#111Formoterol tartrate process and polymorph
#112Amino-substituted ethylamino βadrenergic receptor agonists
#113Halogenated pyrazolo[1,5-A]pyrimidines, processes, uses, compositions and intermediates
#114Acetamide stereoisomer
#115Derivatives of 4-(2-amino-1-hydroxyethyl)phenol as agonists of the β2 adrenergic receptor
#116Beta2-Adrenergic Receptor Agonists
#117Calcium receptor modulating agents
#118N-[2-amino-4-(phenylmethoxy)phenyl] amides and related compounds as potassium channel modulators
#119Process for the synthesis of 6-amino-4-(3-chloro-4-fluorophenylamino)-7-ethoxyquinoline-3-carbonitrile
#120Substituted arylamino-1,2,3,4-tetrahydro naphthalenes and-2,3-dihydro--indenes as potassium channel modulators
#121Formoterol tartrate process and polymorph
#122Diaryl ether βadrenergic receptor agonists
#123Derivatives of 1,3-diamino benzene as potassium channel modulators
#124Processes for preparing substituted N-aryl-N′-[3-(1H-pyrazol-5-YL) phenyl] ureas and intermediates thereof
#125Novel Biphenyl Compounds And Their Use
#126Amine derivatives for the treatment of asthma and COPD
#127Aryl aniline βadrenergic receptor agonists
#128Histone deacetylase inhibitors as therapeutics for neurological diseases
#129Malonamides and malonamide derivatives as modulators of chemokine receptor activity
#130β2-adrenergic receptor agonists
#131Crystalline form of beta2 adrenergic receptor agonist
#132Calcium receptor modulating agents
#133Diphenylamine derivatives
#134Amino alcohol derivatives, medicinal composition containing the same, and use of these
#135Pharmaceutical compositions as inhibitors of dipeptidyl peptidase-IV (DPP-IV)
#136Process for the preparation of -substituted formamides
#137Formoterol tartrate process and polymorph
#138Substituted amino acids as erythropoietin mimetics
#139Substituted p-diaminobenzene derivatives
#140Aryl aniline β2 adrenergic receptor agonists
#141KCNQ channel modulating compounds and their pharmaceutical use
#142Substituted aniline derivatives
#143Aminobenzophenone compounds
#144Substituted aniline derivatives
#145Diaryl ether β2 adrenergic receptor agonists
#146β2-adrenergic receptor agonists
#147Histamine-3 receptor antagonists
#148Substituted hydroxyethylamine aspartyl protease inhibitors
#149Catalytic process for the production of 3,3′, 4,4′-tetraminobiphenyl
#150Aryl aniline βadrenergic receptor agonists
#151Aryl aniline derivatives as βadrenergic receptor agonists
#152β2-adrenoceptor agonists
#153Formoterol tartrate polymorph
#154Calcium receptor modulating agents
#155Substituted cyclic compounds
#156Amino-substituted ethylamino βadrenergic receptor agonists
#157Crystalline beta2 adrenergic receptor agonist
#158Process for the synthesis of 6-amino-4-(3-chloro-4-fluoro-phenylamino)-7-ethoxy-quinoline-3-carbonitrile
#159Substituted cyclic compounds
#160Aminoalcohol derivatives and their use as beta 3 adrenergic agonists
#161Synthesis and pharmaceuticals of novel bis-substituted anthraquinone derivatives